Storb Rainer MD is categorized under Commercial Medical Research in Seattle, WA and active since 2004.
Storb Rainer MD was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Rainer Storb at the company’s single location by writing to 1100 Fairview Avenue North, Seattle, Washington WA 98109 or by phoning (206) 667-4425. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Storb Rainer MD |
| Contact Person: | Rainer Storb |
| Address: | 1100 Fairview Avenue North, Seattle, Washington 98109 |
| Phone Number: | (206) 667-4425 |
| Website Address: | fhcrc.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6211110 |
| Share This Business: |
Storb Rainer MD was started in 2004 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Rainer Storb for inquiries that concern Storb Rainer MD by calling the company number (206) 667-4425, as your correspondence is most welcome. Additionally, the physical location of the single location of Storb Rainer MD can be found at the coordinates 47.629256,-122.330122 as well as the street address 1100 Fairview Avenue North in Seattle, Washington 98109.
For its online presence, you may visit Storb Rainer MD’s website at fhcrc.org and engage with its social media outlets through on Twitter and on Facebook.